RNTX Rein Therapeutics, Inc.
$0.40
Rein Therapeutics, Inc. (RNTX) Earnings News
Earnings press releases, previews and reviews for Rein Therapeutics, Inc. (RNTX), newest first.
Monday
November 16, 2026
7:30 AM ET
Rein Therapeutics Announces Preliminary Blinded Phase 2 RENEW Data Showing Encouraging Lung Function Trends in Patients with Idiopathic Pulmonary Fibrosis and Reports Third Quarter 2026 Financial Results
Thursday
August 20, 2026
8:00 AM ET
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
Friday
August 14, 2026
6:44 AM ET
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update